Rationale behind development of novel drugs for atrial arrhythmias
Topic:
Arrhythmias
Event:
EHRA 2019
Congress Presentation
About the speaker
Associate Professor Jordi Heijman
Faculty of Health, Medicine and Life Sciences Maastricht University, Maastricht (Netherlands (The))
7
presentations
0
follower
4 more presentations in this session
Genetic basis for tailored drug therapy for ventricular arrhythmias
Speaker: Associate Professor C. Remme (Amsterdam, NL)
Access the full session
Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error
Speakers:
Associate Professor J. Heijman, Professor J. Camm, Associate Professor C. Remme, Professor G. Dan
About the event
ESC 365 is supported by
